We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Biotech Research Demands Highly Purified Water

By LabMedica International staff writers
Posted on 26 Apr 2010
Often overlooked, highly purified water is an absolute requirement for successful biotechnology research, and now a new and sophisticated water purification system has become available.

The new purification system, the ELGA LabWater Purelab Pulse, (Marlow, United Kingdom) has been developed to produce consistently highly pure type II level water at economical running costs for a wide range of applications including cell culture and media preparation. More...
Type II water is basic for general laboratory applications requiring higher inorganic purity as well as being suitable for clinical analyzers, electrochemistry, sample dilution, media preparation, and radioimmunoassay.

ELGA's Pulse technology integrates EDI (electrodeionization), which combines ion exchange resins and ion-selective membranes, with direct current to remove ionized impurities from water efficiently. It is complemented by pretreatment, reverse osmosis, and a 254 nm UV lamp to produce type II pure water that the manufacturer says meets and exceeds European, U.S., and Japanese pharmacopeia standards. In addition, the PURELAB Pulse can be fitted with a point-of-use biofilter to reduce bacteria levels to less than one colony-forming unit per 10 mL.

The purification system has been designed to fit into any laboratory environment and is easy to operate and maintain. It can be wall or bench mounted for convenient access and can be fitted with ELGA's unique wrap-around reservoir to save valuable space.

Related Links:
ELGA LabWater



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Automatic CLIA Analyzer
Shine i6000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.